share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股SEC公告 ·  07/09 16:32
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares of the company on 07/09/2024, with an aggregate market value of $109,777.31. The shares were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with a cash payment made on the same date. This planned transaction follows a series of sales over the past three months, where a total of 78,124 shares were sold for gross proceeds of $645,887.34.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares of the company on 07/09/2024, with an aggregate market value of $109,777.31. The shares were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with a cash payment made on the same date. This planned transaction follows a series of sales over the past three months, where a total of 78,124 shares were sold for gross proceeds of $645,887.34.
Recursion Pharmaceuticals公司官員Secora Michael計劃於2024年07月09日賣出公司的15000股A類股票,總市值爲$109,777.31。這些股票最初是在2023年06月13日通過股票期權行使從發行人手中獲得的,當日付現金。這次計劃交易是在過去三個月中一系列銷售交易之後進行的,總共售出78124股,總收入爲$645,887.34。
Recursion Pharmaceuticals公司官員Secora Michael計劃於2024年07月09日賣出公司的15000股A類股票,總市值爲$109,777.31。這些股票最初是在2023年06月13日通過股票期權行使從發行人手中獲得的,當日付現金。這次計劃交易是在過去三個月中一系列銷售交易之後進行的,總共售出78124股,總收入爲$645,887.34。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息